G Protein-Coupled Receptors: Molecular Mechanisms and Novel Functional Insights Organizer(s): Arthur Christopoulos and Michel Bouvier Date: February 17 - 22, 2012
Location: Fairmont Banff Springs, Banff, AB, CanadaThe seven transmembrane-spanning G protein-coupled receptors (GPCRs) are the largest superfamily of receptors in the human genome, are involved in virtually all physiological processes and represent the targets for at least 30% of all current medicines. Recent years have witnessed the coalescing of a number of important paradigms, including ligand-biased signaling, allosteric modulation and receptor dimerization, with substantial advances in structural determination, chemical biology and in vivo approaches to studying GPCR function. These developments will undoubtedly have a profound impact on future approaches to GPCR-based drug discovery. This meeting will focus on the interplay between these developments, and how they can be exploited to advance the translational application of cutting-edge GPCR-based research. Scholarship Deadline: October 17 2011 Discounted Abstract Deadline: October 17 2011 Abstract Deadline: November 18 2011 Discounted Registration Deadline: December 19 2011 We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
AstraZeneca
Eli Lilly and Company
Heptares Therapeutics Ltd
Masataka Harada
We gratefully acknowledge the generous grant for this conference provided by: National Institute on Drug Abuse (NIDA)Grant No. 1R13DA032154-01 The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. |